‘Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study’
08 Apr 2021
Payments from medical device companies totaled $3.6 billion, or $904 million per year during the period. Meanwhile, payments from drug companies totaled $3.3 billion, or $821 million per year. While totals were somewhat similar, medtech payments went to about 135,000 fewer physicians than the pharmaceutical industry, making medical device payments to individual physicians larger
The majority of medtech payments came from 10 big companies, including Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker and Abbott Laboratories.
[BACK TO NEWS]